The global Assisted Reproductive Technology (ART) market is experiencing consistent growth, fueled by rising infertility rates, delayed parenthood, increasing acceptance of fertility treatments, and advancements in clinical reproductive endocrinology. As social and medical factors continue to evolve, more individuals and couples are turning to ART procedures like in vitro fertilization, embryo transfer, and fertility preservation to fulfill their family-building goals.
Market Overview
The assisted reproductive technology market size was valued at USD 28.66 billion in 2024. The market is projected to grow from USD 30.25 billion in 2025 to USD 50.24 billion by 2034, exhibiting a CAGR of 5.8% during 2025–2034.
The surge in ART utilization can be attributed to several factors including increased awareness about infertility treatments, availability of advanced reproductive clinics, and rising incidences of male and female infertility. Lifestyle shifts, such as delayed marriages, late pregnancies, and increased stress, are contributing to reduced fertility rates worldwide.
Technological innovation in reproductive endocrinology, such as time-lapse embryo imaging, genetic testing of embryos (PGT), and cryopreservation techniques, is also improving ART outcomes and making treatments more efficient and accessible.
Key Market Trends
• Delayed Parenthood and Fertility Decline: More individuals are postponing childbirth due to career, financial, or personal reasons, leading to increased reliance on ART services.
• Rising Demand for Fertility Preservation: Cryopreservation of eggs, sperm, and embryos is becoming popular among cancer patients, transgender individuals, and women seeking to delay childbearing.
• Surge in Cross-Border Reproductive Care: Patients are increasingly traveling abroad for affordable or legally accessible ART services, contributing to growth in medical tourism.
• Advancements in Genetic Screening: Preimplantation genetic testing is being integrated with ART to enhance embryo selection and reduce the risk of hereditary diseases.
• Policy Changes and Insurance Coverage: Governments and insurers in some countries are expanding ART coverage, making fertility treatments more accessible to a broader demographic.
Country-Wise Market Analysis
United States
The United States continues to lead the global ART market, owing to its advanced medical infrastructure, high awareness levels, and growing acceptance of non-traditional family structures. Procedures like in vitro fertilization and embryo transfer are widely available, with increasing demand from same-sex couples and single parents. The use of donor eggs, sperm, and gestational carriers is well-established. Rising fertility challenges due to lifestyle factors and environmental toxins are further propelling market growth. Additionally, fertility preservation through egg freezing has seen a steep rise among women in their 30s.
Canada
In Canada, the ART market is expanding steadily, supported by universal healthcare policies and favorable regulatory frameworks. Fertility clinics are witnessing growing demand from individuals seeking treatment under publicly funded or partially subsidized programs. Canadian patients increasingly opt for fertility preservation, particularly among cancer patients and women delaying childbirth. Cross-border fertility travel to the U.S. for more personalized services is also on the rise. Public dialogue around reproductive rights and inclusivity is fueling acceptance and demand for ART services across diverse communities.
United Kingdom
The UK’s ART sector benefits from regulation and guidance under the Human Fertilisation and Embryology Authority (HFEA). The availability of NHS funding for select ART procedures is driving equitable access. The country has seen an increase in same-sex couples and single individuals using ART services. Trends include high uptake of frozen embryo transfer (FET) and advancements in embryo selection via genetic screening. Public awareness campaigns are normalizing ART as a solution to age-related fertility decline.
Germany
Germany is witnessing steady ART market growth, although access is somewhat regulated. Treatments like in vitro fertilization and ICSI (intracytoplasmic sperm injection) are commonly performed in both public and private clinics. Fertility preservation is gaining traction, especially in the context of oncology and social freezing. Increasing numbers of dual-income couples are seeking ART solutions later in life. While regulatory restrictions on egg donation remain, advances in laboratory technologies are improving clinical success rates.
The global Assisted Reproductive Technology (ART) market is experiencing consistent growth, fueled by rising infertility rates, delayed parenthood, increasing acceptance of fertility treatments, and advancements in clinical reproductive endocrinology. As social and medical factors continue to evolve, more individuals and couples are turning to ART procedures like in vitro fertilization, embryo transfer, and fertility preservation to fulfill their family-building goals.
Market Overview
The assisted reproductive technology market size was valued at USD 28.66 billion in 2024. The market is projected to grow from USD 30.25 billion in 2025 to USD 50.24 billion by 2034, exhibiting a CAGR of 5.8% during 2025–2034.
The surge in ART utilization can be attributed to several factors including increased awareness about infertility treatments, availability of advanced reproductive clinics, and rising incidences of male and female infertility. Lifestyle shifts, such as delayed marriages, late pregnancies, and increased stress, are contributing to reduced fertility rates worldwide.
Technological innovation in reproductive endocrinology, such as time-lapse embryo imaging, genetic testing of embryos (PGT), and cryopreservation techniques, is also improving ART outcomes and making treatments more efficient and accessible.
Key Market Trends
• Delayed Parenthood and Fertility Decline: More individuals are postponing childbirth due to career, financial, or personal reasons, leading to increased reliance on ART services.
• Rising Demand for Fertility Preservation: Cryopreservation of eggs, sperm, and embryos is becoming popular among cancer patients, transgender individuals, and women seeking to delay childbearing.
• Surge in Cross-Border Reproductive Care: Patients are increasingly traveling abroad for affordable or legally accessible ART services, contributing to growth in medical tourism.
• Advancements in Genetic Screening: Preimplantation genetic testing is being integrated with ART to enhance embryo selection and reduce the risk of hereditary diseases.
• Policy Changes and Insurance Coverage: Governments and insurers in some countries are expanding ART coverage, making fertility treatments more accessible to a broader demographic.
Country-Wise Market Analysis
United States
The United States continues to lead the global ART market, owing to its advanced medical infrastructure, high awareness levels, and growing acceptance of non-traditional family structures. Procedures like in vitro fertilization and embryo transfer are widely available, with increasing demand from same-sex couples and single parents. The use of donor eggs, sperm, and gestational carriers is well-established. Rising fertility challenges due to lifestyle factors and environmental toxins are further propelling market growth. Additionally, fertility preservation through egg freezing has seen a steep rise among women in their 30s.
Canada
In Canada, the ART market is expanding steadily, supported by universal healthcare policies and favorable regulatory frameworks. Fertility clinics are witnessing growing demand from individuals seeking treatment under publicly funded or partially subsidized programs. Canadian patients increasingly opt for fertility preservation, particularly among cancer patients and women delaying childbirth. Cross-border fertility travel to the U.S. for more personalized services is also on the rise. Public dialogue around reproductive rights and inclusivity is fueling acceptance and demand for ART services across diverse communities.
United Kingdom
The UK’s ART sector benefits from regulation and guidance under the Human Fertilisation and Embryology Authority (HFEA). The availability of NHS funding for select ART procedures is driving equitable access. The country has seen an increase in same-sex couples and single individuals using ART services. Trends include high uptake of frozen embryo transfer (FET) and advancements in embryo selection via genetic screening. Public awareness campaigns are normalizing ART as a solution to age-related fertility decline.
Germany
Germany is witnessing steady ART market growth, although access is somewhat regulated. Treatments like in vitro fertilization and ICSI (intracytoplasmic sperm injection) are commonly performed in both public and private clinics. Fertility preservation is gaining traction, especially in the context of oncology and social freezing. Increasing numbers of dual-income couples are seeking ART solutions later in life. While regulatory restrictions on egg donation remain, advances in laboratory technologies are improving clinical success rates.